TradingViewTradingView

Kewaunee Scientific 2026: Revenue $66.32M, EPS $0.58— 10-Q Summary

Menos de 1 minuto de leitura

Kewaunee Scientific reported results for the quarter ended 2026 with revenue of $66.32M and diluted EPS of $0.58, as demand in domestic lab construction softened versus the prior-year quarter.

Financial Highlights

MetricCurrent quarterPrior year quarterYoY change
Revenue¹$66.32M$71.1M(6.7%)
Net income²$1.71M$3.09M(44.8%)
Diluted EPS³$0.58$1.04(44.2%)

¹ Reported as “Net sales”. ² Reported as “Net earnings attributable to Kewaunee Scientific Corporation”. ³ Reported as “Diluted earnings per share attributable to Kewaunee Scientific Corporation stockholders”.

Business Highlights

  • Revenue decline driven by weaker domestic lab construction demand; overall sales fell to $66.32M from $71.10M a year earlier.
  • Channel mix: LPG segment down 6.4% and international sales down 7.8%, with softness in India partially offset by strength in APAC.
  • Gross margin improved to 29.6%, supported by stronger margins in the International segment and operational improvements.
  • Order backlog stood at $169M versus $205M in the prior-year period; company is focused on converting high quoting activity into awards through commercial and operational initiatives.

Original SEC Filing: KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ] - 10-Q - Sep. 11, 2026

Aviso legal